Nandiwada Sarada L, Li Wei, Zhang Ruan, Mueller Daniel L
Rheumatic and Autoimmune Diseases Division, and Center for Immunology, University of Minnesota Medical School, 312 Church Street SE, Minneapolis, MN 55455, USA.
J Immunol. 2006 Jul 1;177(1):401-13. doi: 10.4049/jimmunol.177.1.401.
During Ag stimulation of T cells, the recognition of B7 molecules by the CD28 costimulatory receptor increases the level of c-Fos, a component of the AP-1 transactivator known to bind the 5' Il2 gene enhancer. In this study, we show that the costimulation of Fos transcription by CD28 is associated with increased binding of p300/CREB-binding protein (CBP) molecules at the Fos promoter, and is blocked by an adenoviral E1A molecular antagonist of p300/CBP. Furthermore, transcriptional activation by a C-terminal domain of CBP is strengthened when CD28 molecules are actively signaling. This increased amount and activity of p300/CBP molecules at the Fos gene correlated with higher histone H4 acetylation and RNA polymerase II association with the promoter. These data suggest a global mechanism whereby CD28 signaling influences the rate and intensity of new gene expression during Ag recognition via direct control over the coactivator function of p300/CBP.
在T细胞受到抗原(Ag)刺激期间,共刺激受体CD28对B7分子的识别会增加c-Fos的水平,c-Fos是AP-1反式激活因子的一个组成部分,已知其可结合5' Il2基因增强子。在本研究中,我们表明CD28对Fos转录的共刺激与p300/CREB结合蛋白(CBP)分子在Fos启动子处结合增加相关,并且被p300/CBP的腺病毒E1A分子拮抗剂所阻断。此外,当CD28分子活跃地发出信号时,CBP C末端结构域的转录激活会增强。Fos基因处p300/CBP分子数量和活性的增加与组蛋白H4乙酰化水平升高以及RNA聚合酶II与启动子的结合相关。这些数据提示了一种整体机制,即CD28信号通过直接控制p300/CBP的共激活因子功能来影响抗原识别过程中新基因表达的速率和强度。